Crossmark Global Holdings Inc. Sells 607 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Crossmark Global Holdings Inc. trimmed its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 4.9% during the third quarter, HoldingsChannel.com reports. The firm owned 11,785 shares of the medical instruments supplier’s stock after selling 607 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $319,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. First Eagle Investment Management LLC increased its position in shares of DENTSPLY SIRONA by 33.6% in the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after acquiring an additional 3,283,965 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after acquiring an additional 1,308,411 shares during the last quarter. Cooke & Bieler LP grew its position in shares of DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after acquiring an additional 1,046,105 shares during the period. National Bank of Canada FI increased its stake in shares of DENTSPLY SIRONA by 684.6% during the 2nd quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier’s stock worth $21,586,000 after purchasing an additional 764,700 shares during the last quarter. Finally, Armistice Capital LLC raised its holdings in shares of DENTSPLY SIRONA by 31.5% in the 2nd quarter. Armistice Capital LLC now owns 2,298,000 shares of the medical instruments supplier’s stock valued at $57,243,000 after purchasing an additional 550,945 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $18.28 on Monday. DENTSPLY SIRONA Inc. has a one year low of $17.21 and a one year high of $37.60. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market cap of $3.63 billion, a price-to-earnings ratio of -8.83, a P/E/G ratio of 1.80 and a beta of 1.02. The stock’s fifty day moving average price is $23.92 and its two-hundred day moving average price is $25.38.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same quarter in the prior year, the business posted $0.49 EPS. The business’s revenue was up .4% compared to the same quarter last year. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

Wall Street Analyst Weigh In

XRAY has been the topic of a number of recent analyst reports. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Needham & Company LLC dropped their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Barrington Research cut their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Finally, Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.